Tas, F. Et Al. 2014. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer. TUMOR BIOLOGY , vol.35, no.4 , 3125-3132.

Tas, F., Karabulut, S., Serilmez, M., Ciftci, R., & Duranyildiz, D., (2014). Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer. TUMOR BIOLOGY , vol.35, no.4, 3125-3132.

Tas, Faruk Et Al. "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer," TUMOR BIOLOGY , vol.35, no.4, 3125-3132, 2014

Tas, Faruk Et Al. "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer." TUMOR BIOLOGY , vol.35, no.4, pp.3125-3132, 2014

Tas, F. Et Al. (2014) . "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer." TUMOR BIOLOGY , vol.35, no.4, pp.3125-3132.

@article{article, author={Faruk TAŞ Et Al. }, title={Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer}, journal={TUMOR BIOLOGY}, year=2014, pages={3125-3132} }